XML 36 R25.htm IDEA: XBRL DOCUMENT

Revenue (Tables)

6 Months Ended

Jun. 30, 2021

Revenue

Schedule of reportable segment included under sales category


		Three Months Ended June 30, 2021									Three Months Ended June 30, 2020
(in millions)		U.S.			Int’l			Total			U.S.			Int’l			Total
Established Pharmaceutical Products —
Key Emerging Markets		$	—		$	915		$	915		$	—		$	764		$	764
Other			—			265			265			—			249			249
Total			—			1,180			1,180			—			1,013			1,013

Nutritionals —
Pediatric Nutritionals			528			565			1,093			484			540			1,024
Adult Nutritionals			345			670			1,015			324			535			859
Total			873			1,235			2,108			808			1,075			1,883

Diagnostics —
Core Laboratory			283			1,023			1,306			289			698			987
Molecular			94			196			290			144			215			359
Point of Care			97			40			137			79			39			118
Rapid Diagnostics			681			833			1,514			345			185			530
Total			1,155			2,092			3,247			857			1,137			1,994

Medical Devices —
Rhythm Management			269			298			567			185			216			401
Electrophysiology			209			278			487			120			179			299
Heart Failure			168			59			227			115			43			158
Vascular			246			451			697			168			313			481
Structural Heart			191			231			422			91			132			223
Neuromodulation			166			44			210			85			21			106
Diabetes Care			289			767			1,056			202			553			755
Total			1,538			2,128			3,666			966			1,457			2,423

Other			15			7			22			7			8			15

Total		$	3,581		$	6,642		$	10,223		$	2,638		$	4,690		$	7,328

Note 3 — Revenue (Continued)


		Six Months Ended June 30, 2021									Six Months Ended June 30, 2020
(in millions)		U.S.			Int’l			Total			U.S.			Int’l			Total
Established Pharmaceutical Products —
Key Emerging Markets		$	—		$	1,736		$	1,736		$	—		$	1,577		$	1,577
Other			—			514			514			—			480			480
Total			—			2,250			2,250			—			2,057			2,057

Nutritionals —
Pediatric Nutritionals			1,036			1,123			2,159			1,002			1,111			2,113
Adult Nutritionals			673			1,312			1,985			618			1,056			1,674
Total			1,709			2,435			4,144			1,620			2,167			3,787

Diagnostics —
Core Laboratory			554			1,934			2,488			556			1,420			1,976
Molecular			269			468			737			209			289			498
Point of Care			189			77			266			182			74			256
Rapid Diagnostics			1,784			1,986			3,770			713			377			1,090
Total			2,796			4,465			7,261			1,660			2,160			3,820

Medical Devices —
Rhythm Management			510			576			1,086			413			462			875
Electrophysiology			388			530			918			284			403			687
Heart Failure			313			108			421			267			94			361
Vascular			465			867			1,332			398			708			1,106
Structural Heart			360			439			799			227			314			541
Neuromodulation			311			83			394			222			61			283
Diabetes Care			542			1,494			2,036			388			1,119			1,507
Total			2,889			4,097			6,986			2,199			3,161			5,360

Other			25			13			38			15			15			30

Total		$	7,419		$	13,260		$	20,679		$	5,494		$	9,560		$	15,054

Schedule of changes in contract liabilities


(in millions)
Contract Liabilities:
Balance at December 31, 2020		$	405
Unearned revenue from cash received during the period			280
Revenue recognized related to contract liability balance			(279)
Balance at June 30, 2021		$	406